Clinical tests begin in Germany, U.S, first result expected in June
133 Total Views
A GERMAN-U.S. coronavirus vaccine has been administered to human test subjects in the U.S., the companies involved reported on Tuesday.
After preliminary tests in Germany, Biontech of Mainz and U.S.-based Pfizer are advancing the clinical trial of BNT162, an mRNA vaccine, in the U.S.
As many as 360 healthy volunteers will be vaccinated in U.S. study — initially only with test subjects between ages 18 and 55 but later also with older participants.
The next round of tests in Germany will involve 200 healthy volunteers age 18 to 55, overseen by Paul Ehrlich Institute, Germany’s federal institute for vaccines.
The first results should be available in June.
If initial tests show a positive result, the tests will continue with more healthy participants as well as high-risk people.
Stop Being Toxic, Respect Other People’s Views, Obi urge supporters
3,358 Total Views Labour Party presidential candidate, Peter Obi has cautioned his supporters and loyalists against being toxic, urging them to…
I never Said Christians should buy Guns — Adeboye reemphasize
3,154 Total Views PASTOR Enoch Adeboye, the General Overseer of the Redeemed Christian Church of God (RCCG), says he never asked…